Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP679254.RADfA83QQcELgYtZf2WXFZA3dehbFJOU5B_0MiNuofOf4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP679254.RADfA83QQcELgYtZf2WXFZA3dehbFJOU5B_0MiNuofOf4130_assertion type Assertion NP679254.RADfA83QQcELgYtZf2WXFZA3dehbFJOU5B_0MiNuofOf4130_head.
- NP679254.RADfA83QQcELgYtZf2WXFZA3dehbFJOU5B_0MiNuofOf4130_assertion description "[Inhibition of PARP has therefore been advanced as a novel targeted therapy for cancers harboring BRCA1/2 mutations.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP679254.RADfA83QQcELgYtZf2WXFZA3dehbFJOU5B_0MiNuofOf4130_provenance.
- NP679254.RADfA83QQcELgYtZf2WXFZA3dehbFJOU5B_0MiNuofOf4130_assertion evidence source_evidence_literature NP679254.RADfA83QQcELgYtZf2WXFZA3dehbFJOU5B_0MiNuofOf4130_provenance.
- NP679254.RADfA83QQcELgYtZf2WXFZA3dehbFJOU5B_0MiNuofOf4130_assertion SIO_000772 21487248 NP679254.RADfA83QQcELgYtZf2WXFZA3dehbFJOU5B_0MiNuofOf4130_provenance.
- NP679254.RADfA83QQcELgYtZf2WXFZA3dehbFJOU5B_0MiNuofOf4130_assertion wasDerivedFrom befree-20140225 NP679254.RADfA83QQcELgYtZf2WXFZA3dehbFJOU5B_0MiNuofOf4130_provenance.
- NP679254.RADfA83QQcELgYtZf2WXFZA3dehbFJOU5B_0MiNuofOf4130_assertion wasGeneratedBy ECO_0000203 NP679254.RADfA83QQcELgYtZf2WXFZA3dehbFJOU5B_0MiNuofOf4130_provenance.